TC
SRNE

Talkot Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Talkot Capital’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-145,500
Closed -$1.68M – 29
2015
Q1 		$1.68M Sell
145,500
-239,057
-62% -$2.77M 1.25% 15
2014
Q4 		$3.87M Sell
384,557
-419,494
-52% -$2.13M 2.92% 9
2014
Q3 		$3.63M Buy
804,051
+108,242
+16% +$581K 2.55% 10
2014
Q2 		$4.7M Buy
+695,809
New +$5.25M 3.23% 10

Other funds holding SRNE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return